Tag: Johnson & Johnson

Healthcare giant Johnson & Johnson to spin off consumer health business

businessnewstoday- November 15, 2021 0

Johnson & Johnson (JNJ) has announced plans to carve out its consumer health business into a new publicly traded company to focus on its biopharma ... Read More

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

Soujanya Ravi- March 27, 2021 0

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson ... Read More

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

businessnewstoday- February 28, 2021 0

Johnson & Johnson (J&J) said that the US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for Ad26.COV2.S, a single-dose COVID-19 vaccine ... Read More

FDA authorizes emergency use of Janssen COVID-19 Vaccine

pharmanewsdaily- February 28, 2021 0

The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine - Ad26.COV2.S manufactured by Johnson & ... Read More

Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis

pharmanewsdaily- January 16, 2021 0

DARZALEX FASPRO FDA approval for AL amyloidosis : Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured approval from the US Food and Drug ... Read More

Janssen seeks EMA’s expanded approval for DARZALEX in AL amyloidosis

pharmanewsdaily- November 8, 2020 0

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a Type II variation application to the European Medicines Agency (EMA) seeking the expanded approval ... Read More

EC strikes deal for supply of JNJ-78436735 Covid-19 vaccine candidate

pharmanewsdaily- October 9, 2020 0

Johnson & Johnson (J&J) said that the European Commission (EC) has approved an advance purchase agreement for securing 200 million doses of the JNJ-78436735 Covid-19 ... Read More

J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

pharmanewsdaily- September 23, 2020 0

ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), ... Read More

Nipocalimab developer Momenta Pharmaceuticals to be acquired by J&J

pharmanewsdaily- August 20, 2020 0

J&J acquisition of Momenta Pharmaceuticals : US healthcare giant Johnson & Johnson (J&J) has signed a $6.5 billion deal to acquire Momenta Pharmaceuticals, a biotech ... Read More

Janssen Covid-19 vaccine candidate Ad26.COV2.S bags $1bn deal from US govt

pharmanewsdaily- August 5, 2020 0

Johnson & Johnson (J&J) said that its subsidiary Janssen Pharmaceutical has agreed to manufacture and supply 100 million doses of its SARS-CoV-2 investigational vaccine Ad26.COV2.S ... Read More